Mercado de Isoladores Farmacêuticos do Médio Oriente e África – Tendências da Indústria e Previsão para 2029

Análise e insights do mercado de isoladores farmacêuticos no Médio Oriente e África

Os isoladores farmacêuticos são utilizados na indústria farmacêutica como um sistema de barreira livre de contaminação. Testes microbiológicos, processamento de terapia celular, fabrico farmacêutico avançado (ATMP) e pesagem, embalagem e distribuição de produtos injetáveis ​​estéreis são apenas algumas aplicações de isoladores farmacêuticos. A utilização de isoladores farmacêuticos é alimentada pelo crescimento contínuo do mercado farmacêutico nos países em desenvolvimento e desenvolvidos e pelo aumento dos gastos em I&D para produzir tratamentos inovadores. Os isoladores médicos avançados e os requisitos da indústria farmacêutica levaram os principais fabricantes a expandir a indústria dos isoladores médicos. O aumento da utilização de compostos perigosos, o aumento do custo da não conformidade e o aumento dos laboratórios de investigação são impulsionadores importantes que impulsionam o mercado dos isoladores farmacêuticos durante o período de previsão.

No entanto, a maioria dos especialistas discorda que as entidades reguladoras já não impeçam avanços como o desenvolvimento de isoladores farmacêuticos.

A Data Bridge Market Research analisa que o mercado de isoladores farmacêuticos do Médio Oriente e África deverá atingir o valor de 232,79 milhões de dólares até 2029, com um CAGR de 12,0% durante o período de previsão. O tipo é responsável pelo maior segmento de tipos do mercado devido à rápida procura de isoladores farmacêuticos no Médio Oriente e em África. Este relatório de mercado também abrange análises de preços, análises de patentes e avanços tecnológicos em profundidade.

Middle East & Africa Pharmaceutical Isolator Market Definition

The isolation concept protects the process from the Operator and or the operator from the process, while protecting the environment. The key to containment, is minimal exposure. By controlling the exposure range below the hazard level set for the compound, the Operator and the environment are properly protected. Hence, the product is protected and therefore a key regulatory issue is addressed. A pharmaceutical isolator is a sealed bacterial enclosure used in the pharmaceutical surrounding for aseptic filling and toxic process. It is made of a perfectly sterile main isolator where the products are handled, stored or packaged using shoulder-high gloves placed on one of the walls. The pharmaceutical isolator enables the control and containment of pharmaceutical processes. The conditions required for working of a pharmaceutical isolator are sterile environment and free of viable microorganisms. A pharmaceutical isolator ensures that production area and aseptic environment are placed in separate positions. A pharmaceutical industry isolator is cost effective and efficient, in comparison to cleanrooms for the pharmaceutical industry in an aseptic environment. It creates a controlled atmosphere during the microbial and drug production process by adjusting with the different standards certification standard required for isolators and restricted access barriers. It ensures the protection of the product, the operators and the environment at the same time.

The abundant applications of pharmaceutical isolators, vary for production and control purposes. It is used while handling, transferring or packing solid semi-solid or powder pharma drugs, handling and filing solutions and infusions. The pharmaceutical isolators are applied in sterility testing, aseptic handling of tissues or biological production systems or pathogenic samples, etc. It can be used for the production and control of drugs and pharmaceutical products. The surge in demand for the isolators across pharmaceutical and biotechnology industry, along with low operational cost, high maintenance of aseptic condition in the production of pharmaceutical products and growing demand of biopharmaceutical industry are the factors expected to drive the market growth, in the forecast period.

Also, strategic initiative by market players, technological progressions in pharmaceutical isolators, high sterility assurance and increasing investment for healthcare infrastructure. These factors increase in the demand for pharmaceutical isolators market.

Middle East & Africa Pharmaceutical Isolator Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:    

Drivers

Growing demand for the pharmaceutical isolators across booming pharmaceutical

Pharmaceutical isolator is a separative device that divides a pharmaceutical procedure or activity from the operator and the adjacent environment. It is used for various purposes such as:

• Providing a categorized aseptic environment for an activity or procedure and guarding it from microbial and non-microbial contamination rising from the operator and adjacent environment which is referred to product protection.
• Protective product from contamination produced by other product and procedure, moreover at the same time or during earlier operations. This is referred to as safeguard against method generated contamination or cross- contamination.

The Increasing contamination problems in the manufacturing unit in which comes isolator that create a demand for Pharmaceutical isolator that helps in contamination and de-contamination.

• Low operational cost of pharmaceutical isolators

Enclosures that are sealed to some standard of leak tightness that comprises inside qualified controlled environment, at modification with the surrounding conditions isolator application reaches from R&D by the production of pharmaceuticals to laboratory use, especially for the microbiological quality control. Whereas pharmaceutical aseptic production has extremely high standards of cleanness almost completely particle free and germ free environments for the aseptic production.

Due to growth in the pharma industry and the widening product range more and more manufacturers and suppliers needs to think about investments in latest added technologies of the clean room technology.

Aseptic processing of the pharmaceutical drugs is the major factor need to be included in good manufacturing practices meeting the government regulations. The high cost of the maintenance of the aseptic condition by clean room technology which is around 62% higher than the pharmaceutical isolators, shifting the manufacturers to acquire isolator’s technology and constraining the overall manufacturing cost of the pharmaceutical products.

Restraint

• Stringent Governmental Regulations               

Active Pharmaceutical Ingredients (API) and intermediates for pharmaceutical use (for instance biological, radiopharmaceutical, and pharmaceutical) and those used to production drugs for clinical trials are regulated under the Divisions 1A and 2, Part C of the Food and Drug Regulations.

• Division 1A, Part C of the Food and Drug Regulations describes activities for which Good Manufacturing Practices (GMP) compliance is required and must be demonstrated prior to the issuance of an API establishment license (EL).
• Division 2, Part C of the Food and Drug Regulations defines the requirements for the GMP of APIs and API intermediates, which are interpreted in the present guidance document.

Due to this strict regulation by the government that has to be followed for the production by the Good Manufacturing Practices (GMP) Guidelines for Active Pharmaceutical Ingredients (API) - (GUI-0104) which constraining the market growth rate.

Opportunity

• Strategic initiatives by market players

The rise in the pharmaceutical isolators market increases the need for strategic business ideas. It includes a partnership, business expansion, and other development. The rising demand for pharmaceuticals is significantly increasing the demand for excipient and to cope with this demand companies are building new manufacturing sites among other strategic initiatives.

These strategic initiatives such as product launches, agreement and business expansion by the major market player will boost the pharmaceutical isolator market growth and is expected to act as an opportunity for the Middle East & Africa medical display market.

Challenge

Lack of skilled expertise

The shortage of skilled expertise would challenge the pace of recovery and growth in one place. Often, the people who are unemployed in one place have skills that are in short supply elsewhere. Moreover, rapid technological advancement in this field also leads to lack of expertise.

Lack of skilled professionals while handling the pharmaceutical isolators poses a major challenge while selecting and developing the pharmaceutical isolators. The data by the Phys.org 2003 mentions the medical display industries are facing a shortage of workers due to increase demand of pharmaceutical isolators in Asia-Pacific region and severe scarcity of micro chips used in LED and LCD display, which increases the price lead times of LCD production.

As skill demands are too high, it has manifested as a challenge to retain and manage skill-specified professionals. Moreover, technological advancement is another aspect that leads to the increased demand for skilled professionals. Neurologists report significant unmet supportive care needs and barriers in their centers with only a small minority rating themselves as competently providing supportive care. There is an urgent need for education of neurologists and professionals for treatment of dementia and procuring available supportive care resources. Lack of trained and experienced professionals and persistent skill gaps limit the employability prospects and access to quality jobs. It is therefore apparent that availability of professionals equipped with adequate skills is expected to challenge the market growth.

Post-COVID-19 Impact on Middle East & Africa Pharmaceutical Isolator Market

The COVID-19 pandemic has become the world's most serious threat. It wreaked havoc in many stores and businesses around the world. The pandemic, on the other hand, has provided many opportunities for pharmaceutical and biopharmaceutical companies to expand their research and development activities to develop new vaccines against the new coronavirus. Companies are conducting clinical trials to try to stop the spread of the COVID-19 virus. Pharmaceutical insulator suppliers to biopharmaceutical organizations have more opportunities as the number of clinical trials increases.

Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launch and strategic partnerships to improve the technology and test results involved in the pharmaceutical medical display market.

Recent Developments

• In June 2022, the company announced a partnership with Medical Supply Company (MSC) to market and service Jacomex equipment to the pharmaceutical and pharmaceutical industries in Ireland. MSC has many years of recognized expertise in the market with field teams closest to customers and company’s commercial team currently working abroad had the pleasure of welcoming Cian Murphy and finalizing the agreement between Jacomex and MSC. The beginning of a long and fruitful collaboration. This has helped the company to expand their business.
• In January 2022, Clario partnered with XingImaging, a radiopharmaceutical production and positron emission tomography (PET) acquisition company, to deliver PET imaging clinical trials for testing novel therapeutics in China. The partnership offers to share the joint resources and neuroscience experts of Clario and XingImaging to expedite the startup of clinical trials and drug discovery in China.

Middle East & Africa Pharmaceutical isolator market Scope

Middle East & Africa pharmaceutical isolator market is segmented into type, pressure, application, configuration, system type, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE

• ASEPTIC ISOLATORS
• CONTAINMENT ISOLATORS
• BIO ISOLATORS
• SAMPLING AND WEIGHING ISOLATORS
• ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS
• RADIOPHARMACEUTICAL ISOLATORS
• PRODUCTION ISOLATORS
• OTHERS

On the basis of type, the Middle East & Africa pharmaceutical isolator market is segmented into aseptic isolators, containment isolators, bio isolators, sampling and weighing isolators, active pharmaceutical ingredient (API) manufacturing isolators, radiopharmaceutical isolators, production isolators, others.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE

• CLOSED SYSTEM
• OPEN SYSTEM

On the basis of system type, the Middle East & Africa pharmaceutical isolator market is segmented into closed system, open system.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE

• POSITIVE PRESSURE
• NEGATIVE PRESSURE

On the basis of pressure, the Middle East & Africa pharmaceutical isolator market is segmented into positive pressure and negative pressure.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION

• FLOOR STANDING
• MODULAR
• MOBILE
• COMPACT
• TABLE TOP
• PORTABLE
• OTHERS

Com base na configuração, o mercado de isoladores farmacêuticos do Médio Oriente e África está segmentado em pavimento, modular, móvel, compacto, de mesa, portátil, outros.

MERCADO DOS ISOLADORES FARMACÊUTICOS NO MÉDIO ORIENTE E EM ÁFRICA, POR APLICAÇÃO

• TESTE DE ESTERILIDADE
• FABRICAÇÃO
• AMOSTRAGEM/ PESAGEM/ DISTRIBUIÇÃO
• FABRICAÇÃO DE DISPOSITIVOS MÉDICOS
• OUTROS

Com base na aplicação, o mercado de isoladores farmacêuticos do Médio Oriente e África está segmentado em testes de esterilidade, fabrico, amostragem/pesagem/distribuição, fabrico de dispositivos médicos, outros.

MERCADO DE ISOLADORES FARMACÊUTICOS NO MÉDIO ORIENTE E EM ÁFRICA, POR UTILIZADOR FINAL

• HOSPITAIS
• LABORATÓRIOS DE DIAGNÓSTICO
• INSTITUTOS ACADÉMICOS E DE INVESTIGAÇÃO
• EMPRESAS FARMACÊUTICAS E DE BIOTECNOLOGIA
• ORGANIZAÇÕES DE PESQUISA DE CONTRATOS
• OUTROS

Com base no utilizador final, o mercado de isoladores farmacêuticos do Médio Oriente e África está segmentado em hospitais, laboratórios de diagnóstico, institutos académicos e de investigação, empresas farmacêuticas e de biotecnologia, organizações de investigação por contrato, outros.

MERCADO DE ISOLADORES FARMACÊUTICOS NO MÉDIO ORIENTE E EM ÁFRICA, POR CANAL DE DISTRIBUIÇÃO

• CONCURSO DIRETO
• VENDAS NO VAREJO
• DISTRIBUIDORES TERCEIROS

Com base no canal de distribuição, o mercado de isoladores farmacêuticos do Médio Oriente e África está segmentado em concurso direto, vendas a retalho e distribuidores de terceiros.

Análise/perspetivas regionais do mercado de isoladores farmacêuticos do Médio Oriente e África

O mercado de isoladores farmacêuticos do Médio Oriente e África é analisado e são fornecidas informações sobre o tamanho do mercado: tipo, pressão, aplicação, configuração, tipo de sistema, utilizador final e canal de distribuição.

Os países abrangidos neste relatório de mercado são a África do Sul, Arábia Saudita, Emirados Árabes Unidos, Egito, Israel e resto do Médio Oriente e África.

Em 2022, a África do Sul está a dominar devido aos avanços tecnológicos no isolador farmacêutico e ao aumento do futuro da tecnologia robótica na indústria dos isoladores farmacêuticos

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Dados como novas vendas, vendas de reposição, demografia do país, atos regulamentares e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas do Médio Oriente e África e os desafios enfrentados devido à concorrência grande ou escassa de marcas locais e nacionais, e o impacto dos canais de vendas, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.

Cenário competitivo e análise da quota de mercado de isoladores farmacêuticos no Médio Oriente e África

O panorama competitivo do mercado de isoladores farmacêuticos do Médio Oriente e África fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em I&D, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, pipelines de testes de produtos, aprovações de produtos, patentes, largura e respiração do produto, domínio da aplicação, curva da linha de vida da tecnologia. Os dados acima fornecidos estão apenas relacionados com o foco da empresa no mercado de isoladores farmacêuticos do Médio Oriente e África.

Alguns dos principais players que operam no mercado de isoladores farmacêuticos do Médio Oriente e África são a Getinge, SKAN AG, Hosokawa micron ltd, Gelman Singapore, Azbil Corporation, Germfree Laboratories, Inc., M. Braun Inertgas-Systeme Gmbh, Nuaire, Iteco SRL , Comecer SPA, Hecht Technologie Gmbh, Steriline SRL, Envair Limited, Tema Sinergie SPA, Indústrias de Engenharia Esquemática, Chiyoda Corporation, Chamunda Pharma Machinery Unip. Ltd, Bioquell (Ecolab Solution), Jacomex, Fedegari Autoclavi SpA, LAF Technologies, ISO Tech Design, Cytiva, Esco Pharma.

Metodologia de Investigação: Mercado de Isoladores Farmacêuticos do Médio Oriente e África

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Além disso, os modelos de dados incluem a grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise da quota de mercado da empresa, padrões de medição, Médio Oriente e África vs Regional e análise da participação dos fornecedores. Solicite a chamada do analista em caso de dúvidas adicionais.

SKU-35231